Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs

Bindraban, AN; Rolvink, J; Berger, FA; van den Bemt, PMLA; Kuijper, AFM; van der Hoeven, RTM; Mantel-Teeuwisse, AK; Becker, ML

Becker, ML (reprint author), Haarlem Hosp, Pharm Fdn, Boerhaavelaan 24, NL-2035 RC Haarlem, Netherlands.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018; 40 (5): 1372